Hybrid AF™ Therapy with the EPi-Sense System is the first and ONLY FDA-approved device for minimally invasive ablation therapy to treat LSPAF—the most prevalent and undertreated Afib patient population.
Discover the EPi-Sense ST™ device: <a href="https://t.co/g3826PEY8H" target="_blank">https://t.co/g3826PEY8H</a>